Ondine Biomedical Inc (LON:OBIMF) | WebDisclosure

Basculer en Français

10630	Companies
225961	Keywords
154508	Articles
119607	Press releases

Headlines Articles Press releases Ondine Biomedical Inc

Home
Companies
Ondine Biomedical Inc

PRESS RELEASE

published on 04/15/2024 at 08:00, 2 years 2 months ago

Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin
Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available

Steriwave Cost Savings Mazankowski Alberta Heart Institute Cardiac Infections Antimicrobial Treatment
BRIEF

published on 04/10/2024 at 08:05, 2 years 2 months ago

Ondine Biomedical Inc.'s Steriwave Cleared for Use in HCA Healthcare UK Facilities

Antimicrobial Resistance Steriwave Healthcare-associated Infections HCA Healthcare UK Antibiotic Reduction
BRIEF

published on 04/10/2024 at 08:05, 2 years 2 months ago

Steriwave d'Ondine Biomedical Inc. autorisé à être utilisé dans les établissements HCA Healthcare au Royaume-Uni

Steriwave Infections Nosocomiales Résistance Aux Antimicrobiens HCA Healthcare Royaume-Uni Réduction Des Antibiotiques
PRESS RELEASE

published on 04/10/2024 at 08:00, 2 years 2 months ago

Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK
HCA UK authorizes Steriwave antimicrobial by Ondine Biomedical to combat healthcare-associated infections without inducing antimicrobial resistance. Approval allows wider adoption in healthcare facilities

Antimicrobial Resistance Healthcare Facilities Steriwave Ondine Biomedical HCA UK
BRIEF

published on 04/04/2024 at 08:05, 2 years 2 months ago

Ondine Biomedical Inc. Expands into ICU Market with Steriwave®

Antimicrobial Resistance Steriwave Ondine Biomedical Healthcare-associated Infections Intensive Care Unit
BRIEF

published on 04/04/2024 at 08:05, 2 years 2 months ago

Ondine Biomedical Inc. se développe sur le marché des soins intensifs avec Steriwave®

Steriwave Ondine Biomedical Infections Nosocomiales Résistance Aux Antimicrobiens Unité De Soins Intensifs
PRESS RELEASE

published on 04/04/2024 at 08:00, 2 years 2 months ago

Ondine Biomedical Inc. Announces Entry into ICU Market Expands Revenue Potential
Ondine Biomedical plans entry into ICU market following interest from Canadian Hospitals. The move aims to reduce infections with Steriwave® treatment without triggering antimicrobial resistance. Cost savings for hospitals expected

Antimicrobial Resistance Ondine Biomedical ICU Market Steriwave® Hospital Infections
BRIEF

published on 03/25/2024 at 08:05, 2 years 2 months ago

Ondine Biomedical Inc. Achieves Commercial Adoption of Steriwave in NHS Hospitals

Antimicrobial Resistance Ondine Biomedical Inc. Steriwave Surgical Site Infections NHS
BRIEF

published on 03/25/2024 at 08:05, 2 years 2 months ago

Ondine Biomedical Inc. parvient à l'adoption commerciale de Steriwave dans les hôpitaux du NHS

Steriwave Infections Du Site Opératoire NHS Ondine Biomédicale Inc. Résistance Aux Antimicrobiens
PRESS RELEASE

published on 03/25/2024 at 08:00, 2 years 2 months ago

Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS
NHS hospitals adopt groundbreaking light-activated antimicrobial, Steriwave, to combat AMR and reduce surgical infections. Ondine Biomedical partners with NHS for further adoption

Steriwave Ondine Biomedical NHS Hospitals Light-activated Antimicrobial Surgical Infections

Accesswire

Published on 06/25/2026 at 00:30, 3 hours 20 minutes ago

Northern Dynasty Reports Annual General Meeting Results and Welcomes New Directors
Published on 06/24/2026 at 23:05, 4 hours 45 minutes ago

Polaris Modifies Quorum Requirement for Upcoming AGM
Published on 06/24/2026 at 22:15, 5 hours 35 minutes ago

Organto Foods Announces Annual General Meeting Results
Published on 06/24/2026 at 21:20, 6 hours 30 minutes ago

Taranis to Explore New Properties East of Thor Mineral Resource
Published on 06/24/2026 at 20:10, 7 hours 40 minutes ago

Fox River Obtains Final Order Approving Plan of Arrangement With Avenir Minerals Limited

View all ACCESSWIRE

EQS Group

Published on 06/25/2026 at 03:20, 30 minutes ago

ZTT at Intersolar Europe 2026: Full-Industry-Chain Strength Powering a Low-Carbon Future
Published on 06/24/2026 at 23:57, 3 hours 53 minutes ago

OHB: Upsized private placement worth EUR 900 million successfully completed
Published on 06/24/2026 at 20:54, 6 hours 55 minutes ago

EQS-Adhoc: Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/24/2026 at 18:29, 9 hours 21 minutes ago

Designated Person Notification
Published on 06/24/2026 at 18:29, 9 hours 21 minutes ago

Designated Person Notification

Les Echos

Published on 06/24/2026 at 19:00, 8 hours 50 minutes ago

ALTAREA - Succès de l’option pour le paiement du dividende en actions : taux de souscription de 78,5 %
Published on 06/24/2026 at 18:00, 9 hours 50 minutes ago

Annual Results 2025-26
Published on 06/24/2026 at 18:00, 9 hours 50 minutes ago

CP résultats annuels 2025-26
Published on 06/24/2026 at 18:00, 9 hours 50 minutes ago

KERLINK : Assemblée générale mixte des actionnaires du 23 juin 2026 Seconde convocation le 9 juillet 2026.
Published on 06/24/2026 at 17:45, 10 hours 5 minutes ago

Air Liquide poursuit son développement au Kazakhstan avec un investissement clé pour le complexe industriel de Silleno

View all LES ECHOS COMFI WIRE